Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Background/Objectives: Photoimmunotherapy (PIT) is an innovative approach for the targeted therapy Western Trail of cancer.In PIT, photosensitizer dyes are conjugated to tumor-specific antibodies for targeted delivery into cancer cells.Upon irradiation with visible light, the photosensitizer dye is activated and induces cancer-specific cell death.I